Parenteral Nutrition Market Poised for Significant Growth from 2025 to 2032 Featuring AbbVie Inc., Danone, and Fresenius Kabi AG

The parenteral nutrition industry is witnessing significant advancements driven by rising incidences of chronic diseases, increasing healthcare expenditure, and growing demand for specialized nutritional therapies. Innovations in formulation and delivery systems are expanding the application scope, particularly in critical care and oncology settings. The Global Parenteral Nutrition Market size is estimated to be valued at USD 4,548.7 Million in 2025 and is expected to reach USD 6,939 Million by 2032, exhibiting a compound annual growth rate (CAGR) of 6.2% from 2025 to 2032. This steady growth reflects enhanced clinical adoption and a broader understanding of nutrition's role in patient recovery and morbidity reduction.

➔ Request a sample Report Now to explore the full potential: https://www.coherentmarketinsights.com/insight/request-sample/4804

➤Actionable Insights

● Supply-side dynamics indicate a 12% increase in production capacity of parenteral nutrition solutions globally in 2024, driven by expansions in manufacturing facilities across Asia Pacific. This capacity growth supports the rising market revenue and enables prompt fulfillment of hospital and homecare demands.
● Pricing trends reveal a moderate annual price increase of approximately 3.5% between 2023 and 2024, attributed to raw material cost inflation and advanced nutrient formulations incorporating amino acids and lipids, enhancing clinical effectiveness.
● Demand-side analysis shows a surge in imports of specialized parenteral nutrition products in North America, with a 15% year-on-year rise reported in 2024, primarily to serve growing geriatric and oncology patient pools.
● Use cases across hospitals and long-term care facilities have diversified, with neonatal intensive care units reporting a 10% rise in parenteral nutrition administration in 2025, correlating with improved survival rates of preterm infants. Such micro-indicators underscore the evolving clinical reliance on parenteral nutrition therapies and the expanding market scope.

➤Market Segment and Regional Coverage

● By Product Type: Amino Acids, Lipids, Dextrose, Electrolytes, and Others.
● By Application: Hospitals, Homecare, Ambulatory Care, and Others.
● By End User: Adult Patients, Pediatric Patients, Neonatal Patients, and Others.

● Regional and Country Analysis:
● North America: U.S. and Canada
● Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
● Europe: Germany, U.K., Spain, France, Italy, Benelux, Denmark, Norway, Sweden, Russia, and Rest of Europe
● Asia Pacific: China, Taiwan, India, Japan, South Korea, Indonesia, Malaysia, Philippines, Singapore, Australia, and Rest of Asia Pacific
● Middle East & Africa: Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates, Israel, South Africa, North Africa, Central Africa, and Rest of MEA

➔ Elevate your business strategy with comprehensive market data. Request a sample report now: https://www.coherentmarketinsights.com/insight/request-sample/4804

➤Key Players

● AbbVie Inc.
● Danone
● Fresenius Kabi AG
● GENTAG, Inc.
● GSK plc.
● Nestlé SA
● Nutricia
● Sun Pharmaceutical Industries Ltd
● Pfizer Inc.
● Sanofi
● Otsuka Holdings Co., Ltd.
● Baxter International Inc.
● B. Braun Melsungen AG
● Baxter Healthcare Corporation
● Medline Industries, Inc.
● Becton Dickinson and Company
● Cardinal Health, Inc.
● Terumo Corporation
● Competitive strategies observed include Fresenius Kabi AG's recent acquisition of a specialty parenteral nutrition company in 2024, which expanded its product portfolio and increased its market share by 5%. Meanwhile, Nestlé SA intensified its R&D investment in lipid-based formulations, resulting in a 7% revenue growth from innovative parenteral nutrition products in 2025. AbbVie Inc. focused on strategic partnerships with hospital networks in the U.S., enhancing its distribution and capturing emerging market segments effectively.

➤Growth factors

● The parenteral nutrition market growth is propelled by the increasing prevalence of gastrointestinal diseases, cancer, and critical illnesses requiring tailored nutritional interventions. For instance, the U.S. reported a 9% rise in home parenteral nutrition patients in 2024, highlighting a shift towards outpatient care models.
● Advances in clinical protocols and improved safety standards have increased clinician confidence, leading to a 6% annual increase in hospital parenteral nutrition prescriptions globally.
● Additionally, rising geriatric populations in Europe and Asia Pacific contribute to sustained demand, with the elderly demographic in Asia Pacific growing at 4.5% annually, accentuating the industry's long-term growth trajectory.

➔ Get Instant Access! Purchase Research Report and receive a 25% Discount: https://www.coherentmarketinsights.com/insight/buy-now/4804

Key Reasons for Buying the Parenteral Nutrition Market Report:
✦ Comprehensive analysis of the changing competitive landscape
✦ Assists in decision-making processes for the businesses along with detailed strategic planning methodologies
✦ The report offers forecast data and an assessment of the Parenteral Nutrition Market
✦ Helps in understanding the key product segments and their estimated growth rate
✦ In-depth analysis of market drivers, restraints, trends, and opportunities
✦ Comprehensive regional analysis of the Parenteral Nutrition Market
✦ Extensive profiling of the key stakeholders of the business sphere
✦ Detailed analysis of the factors influencing the growth of the Parenteral Nutrition Market

➤ Market Trends

● Increasing integration of digital health technologies, including smart infusion pumps and remote monitoring, is revolutionizing parenteral nutrition delivery, reducing errors by nearly 15% according to a 2024 multicenter study.
● Customization of nutrient formulations based on patient genomics and metabolic profiles is gaining traction, with pilot programs in Europe reporting improved patient outcomes and shorter hospital stays by 12%.
● Sustainability efforts are influencing packaging innovations, with biodegradable and recyclable materials gaining adoption by market companies, driven by regulatory pressures in North America and Europe since 2023.

➤Market Opportunities

● By Product Segment: The lipid emulsion segment offers substantial growth potential due to emerging evidence of improved immunomodulatory effects, with a projected CAGR of over 7% from 2025 to 2032.
● By Application Segment: Homecare parenteral nutrition is witnessing rapid expansion, fueled by patient preference for outpatient care and telehealth integration, with market revenue expected to grow by 8% annually through 2030.
● By End User Segment: Neonatal patients represent a critical opportunity, as rising premature birth rates worldwide necessitate specialized nutrition, driving segment growth by 9% in 2024 alone.
● Regional Opportunity: Asia Pacific displays the highest market growth potential, supported by increasing healthcare infrastructure investments and a rising incidence of chronic diseases, with the region's market share expanding by 6.8% in 2024.

❓ Frequently Asked Questions

● Who are the dominant players in the Parenteral Nutrition Market?
The dominant players include AbbVie Inc., Danone, Fresenius Kabi AG, GSK plc., Nestlé SA, and Pfizer Inc., among others. These companies lead by leveraging innovation, strategic acquisitions, and expanding distribution networks to solidify their market share.

● What will be the size of the Parenteral Nutrition Market in the coming years?
The market size is projected to grow from USD 4,548.7 Million in 2025 to USD 6,939 Million by 2032, exhibiting a CAGR of 6.2% during the forecast period.

● Which end user industry has the largest growth opportunity?
The neonatal patient segment is anticipated to have the largest growth opportunity due to increasing preterm births and the need for specialized nutritional support in neonatal intensive care units.

● How will market development trends evolve over the next five years?
Market trends indicate enhanced personalization of parenteral nutrition formulations, integration of digital delivery systems, and sustainability-driven packaging innovations, all contributing to improved patient outcomes and operational efficiencies.

● What is the nature of the competitive landscape and challenges in the Parenteral Nutrition Market?
The competitive landscape is dynamic, characterized by mergers and acquisitions, product innovation, and geographic expansion. Challenges include regulatory compliance, raw material price volatility, and ensuring formulation safety and efficacy.

● What go-to-market strategies are commonly adopted in the Parenteral Nutrition Market?
Key strategies include strategic partnerships with healthcare providers, investment in R&D for advanced formulations, and expansion into emerging markets, supported by robust supply chain enhancements.

Author of this marketing PR:

Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from Openpr her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice's dedication to excellence and her strategic approach to content make her an invaluable asset in the world of market insights.

About Us:
Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries.

Contact Us:

Mr. Shah
Coherent Market Insights
533 Airport Boulevard,
Suite 400, Burlingame,
CA 94010, United States
US: + 12524771362
UK: +442039578553
AUS: +61-8-7924-7805
India: +91-848-285-0837

This release was published on openPR.